ChristianaCare’s Helen F. Graham Cancer Center & Research Institute has become the first facility in Delaware to offer CARVYKTI, a chimeric antigen receptor (CAR) T-cell therapy for adults with relapsed or treatment-resistant multiple myeloma, a rare but serious form of blood cancer. “CAR-T cell therapy represents a paradigm shift in the treatment of multiple myeloma,” said Dr. Thomas Schwaab, Bank …
Delaware to offer statewide lung cancer screening Saturday
Delaware on Saturday, Nov. 12, will become the first to offer statewide lung cancer screening, using five facilities up and down the state. The day was chosen deliberately to remove barriers for people who can’t make it Monday through Friday because they work, or have to rely on someone who does. It also coincides with the American Cancer Society’s National …